EDSA

Edesa Biotech Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Value↑ 5/10
Edesa Biotech sales and earnings growth
EDSA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 15.72%
  • FCF Y/Y↓ -31.48%
Edesa Biotech gross and profit margin trends
EDSA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 1565.72%
Edesa Biotech net debt vs free cash flow
EDSA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Edesa Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks